184764-13-4: Montelukast (3S) Hydroxy Methyl Ketone
Montelukast (3S) Hydroxy Methyl Ketone (CAS No: 184764-13-4) or Montelukast keto Hydroxy is an impurity present in montelukast which is a potent and selective leukotriene D4 receptor antagonist used in the prophylaxis and treatment of chronic asthma. It blocks CysLT1 in the lungs and thus bronchial tubes, decreasing bronchoconstriction.
Additional information on CAS 184764-13-4
Catalogue No.
VL510018
CAS No.
184764-13-4
Molecular Formula
C28H24ClNO2
Molecular Weight
441.95 g/mol
Parent drug
Montelukast
IUPAC Name
1-[2-[(3S)-3-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-hydroxypropyl]phenyl]acetate
Synonyms
Montelukast keto Hydroxy; [S-(E)]-1-[2-[3-[3-[2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-hydroxypropyl]phenyl]ethanone;
Smiles
CC(=O)C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)O
References
–
Status
In-stock
